Liquidia (LQDA) Assets Average (2021 - 2026)
Liquidia's (LQDA) quarterly Assets Average came in at $364.7 million in Q1 2026, up 59.36% year-on-year from $228.9 million in Q1 2025, and up 20.79% quarter-over-quarter from $302.0 million in Q4 2025.
Liquidia (LQDA) Assets Average (2021 - 2026) Analysis & Trends
Liquidia's Assets Average history runs 6 years deep, the most recent figure standing at $364.7 million for Q1 2026.
- On a quarterly basis, Assets Average rose 59.36% year-over-year to $364.7 million in Q1 2026; TTM through Mar 2026 was $364.7 million, a 59.36% increase from a year earlier, with the FY2025 full-year figure at $279.1 million, up 60.12% from the prior year.
- Assets Average grew to $364.7 million in Q1 2026 per LQDA's latest filing, from $302.0 million in the prior quarter.
- Across five years, Assets Average topped out at $364.7 million in Q1 2026 and bottomed at $93.6 million in Q1 2022.
- The 5-year median for Assets Average is $157.7 million (2024), against an average of $186.4 million.
- Across the five-year window, Assets Average dropped 14.14% in 2023 and jumped 110.11% in 2024, its largest moves.
- Year by year, Assets Average stood at $130.9 million in 2022, then declined by 12.15% to $115.0 million in 2023, then soared by 110.11% to $241.6 million in 2024, then gained by 24.98% to $302.0 million in 2025, then gained by 20.79% to $364.7 million in 2026.
- Per Business Quant, the three latest LQDA Assets Average figures stand at $364.7 million (Q1 2026), $302.0 million (Q4 2025), and $266.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 364.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 364.73 Mn |
| Dec 31, 2025 | 301.96 Mn |
| Sep 30, 2025 | 266.70 Mn |
| Jun 30, 2025 | 242.42 Mn |
| Mar 31, 2025 | 228.87 Mn |
| Dec 31, 2024 | 241.60 Mn |
| Sep 30, 2024 | 215.12 Mn |
| Jun 30, 2024 | 187.24 Mn |
| Mar 31, 2024 | 157.72 Mn |
| Dec 31, 2023 | 114.99 Mn |
| Sep 30, 2023 | 116.62 Mn |
| Jun 30, 2023 | 125.26 Mn |
| Mar 31, 2023 | 129.06 Mn |
| Dec 31, 2022 | 130.88 Mn |
| Sep 30, 2022 | 135.83 Mn |
| Jun 30, 2022 | 116.30 Mn |
| Mar 31, 2022 | 93.63 Mn |
| Dec 31, 2021 | 97.01 Mn |
| Sep 30, 2021 | 102.34 Mn |
| Jun 30, 2021 | 96.42 Mn |